These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6357970)

  • 1. Experimental model of Klebsiella infection in mice for studies on mechanisms of local immunity of the respiratory tract.
    Libich J; Franĕk J; Hásková V
    Folia Microbiol (Praha); 1983; 28(5):424-9. PubMed ID: 6357970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local immunity to klebsiella pneumoniae in the lungs of mice.
    Cooper JM; Finlay-Jones JJ; Hill NL; Rowley D
    J Infect Dis; 1983 Feb; 147(2):312-7. PubMed ID: 6338131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The intensity and dynamics of the development of immunity in the administration of experimental corpuscular ozena vaccines].
    Molochko VA; Krasil'nikov AP; Krylov IA; Lastochkina TM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):49-52. PubMed ID: 3414235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Contributions of Neutrophils and CCR2+ Monocytes to Pulmonary Clearance of Different Klebsiella pneumoniae Strains.
    Xiong H; Carter RA; Leiner IM; Tang YW; Chen L; Kreiswirth BN; Pamer EG
    Infect Immun; 2015 Sep; 83(9):3418-27. PubMed ID: 26056382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A murine model demonstrates capsule-independent adaptive immune protection in survivors of
    Twentyman J; Morffy Smith C; Nims JS; Dahler AA; Rosen DA
    Dis Model Mech; 2020 Mar; 13(3):. PubMed ID: 32298236
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of a hydroxylamine Klebsiella vaccine on the rate of elimination of the causative agent and on indices of humoral immunity].
    Kurbatova EA; Lazareva ES; Gladus MA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Sep; (9):75-9. PubMed ID: 3061265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model.
    Lawlor MS; Hsu J; Rick PD; Miller VL
    Mol Microbiol; 2005 Nov; 58(4):1054-73. PubMed ID: 16262790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia.
    Karaolis DK; Newstead MW; Zeng X; Hyodo M; Hayakawa Y; Bhan U; Liang H; Standiford TJ
    Infect Immun; 2007 Oct; 75(10):4942-50. PubMed ID: 17646358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Klebsiella pneumoniae type 3 fimbria-mediated immunity to infection in the murine model of respiratory disease.
    Lavender H; Jagnow JJ; Clegg S
    Int J Med Microbiol; 2005 Jun; 295(3):153-9. PubMed ID: 16047414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informative value of a mouse model of Klebsiella pneumoniae infection used as a host-resistance assay.
    Malina J; Hofmann J; Franĕk J
    Folia Microbiol (Praha); 1991; 36(2):183-91. PubMed ID: 1823654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural and acquired resistance of mice to infection by airborne Klebsiella pneumoniae after subchronic intoxication by cadmium administered orally.
    Bouley G; Arsac F; Dubreuil A; Boudene C; Pekari K
    Sci Total Environ; 1984 Sep; 38():55-62. PubMed ID: 6395338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model.
    Hussein KE; Bahey-El-Din M; Sheweita SA
    Microb Pathog; 2018 Jun; 119():12-18. PubMed ID: 29626658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protective activity of a cell-free Klebsiella vaccine in relation to different Klebsiella pneumoniae serovars].
    Kurbatova EA; Egorova NB; Kiseleva BS
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):80-3. PubMed ID: 6385585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of various routes of vaccination and testing. An instance of a killed bacterial vaccine].
    Binder P; du Colombier P; Bureau Fontanges R
    Poumon Coeur; 1982; 38(5):317-23. PubMed ID: 6760155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the host responses to wild-type and cpsB mutant Klebsiella pneumoniae infections.
    Lawlor MS; Handley SA; Miller VL
    Infect Immun; 2006 Sep; 74(9):5402-7. PubMed ID: 16926436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo study on the immunomodulating effects of OM-85 BV on survival, inflammatory cell recruitment and bacterial clearance in Klebsiella pneumonia.
    Broug-Holub E; Kraal G
    Int J Immunopharmacol; 1997; 19(9-10):559-64. PubMed ID: 9637354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction & resolution of lobar pneumonia following intranasal instillation with Klebsiella pneumoniae in mice.
    Yadav V; Sharma S; Harjai K; Mohan H; Chhibber S
    Indian J Med Res; 2003 Jul; 118():47-52. PubMed ID: 14748466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide-mediated protection against Klebsiella pneumoniae-induced lobar pneumonia: intranasal vs. intramuscular route of immunization.
    Yadav V; Sharma S; Harjai K; Mohan H; Chhibber S
    Folia Microbiol (Praha); 2005; 50(1):83-6. PubMed ID: 15954538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Klebsiella pneumoniae to Model Acute Lung Inflammation in Mice.
    McDaniel DK; Allen IC
    Methods Mol Biol; 2019; 1960():169-180. PubMed ID: 30798531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
    Skelding KA; Hickey DK; Horvat JC; Bao S; Roberts KG; Finnie JM; Hansbro PM; Beagley KW
    Vaccine; 2006 Jan; 24(3):355-66. PubMed ID: 16153755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.